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BACKGROUND: The independent and combined effects of socioeconomic status (SES), viral hepatitis, and other lifestyle factors on
hepatocellular carcinoma (HCC) risk have not been investigated among Koreans.
METHODS: From the National Cancer Center Hospital, 207 HCC cases and 828 age- and gender-matched controls aged 30 years or older were
recruited. Socio-demographic and behavioural risk factors were ascertained through personal interview, and infection with hepatitis B and C
viruses was determined by their serologic markers. Multivariate logistic regression and synergy index methods were applied for statistical analysis.
RESULTS: HB surface antigen (HbsAg) and anti-HCV-positive rates were 149.3 and 185.1 times higher in cases than controls,
respectively. Lifetime alcohol consumption (odds ratio: 2.96, 95% CI: 1.29–6.79), cigarette smoking (OR: 3.53, 95% CI: 1.31–9.52),
and family income (OR: 17.07, 95% CI: 4.27–68.25) were independently associated with the risk of HCC in subjects with or
without viral hepatitis. Synergistic interaction on HCC risk was observed between low income and HBsAg positivity (SI: 3.12,
95% CI: 1.51–6.47) and between low income and heavy alcohol intake (SI: 2.93, 95% CI: 1.24–6.89).
CONCLUSION: The inverse association with SES suggests SES as an independent and synergistic predictor of HCC. Heavy alcohol intake
also showed a combined effect with low SES on HCC risk.
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Hepatocellular carcinoma (HCC, ICD-10 code: C22. 0) is one of the
most common cancers worldwide, with high incidence in Asia and
Africa and increasing rates in North America and Western Europe
(Curado et al, 2007; Gomaa et al, 2008; World Health Organization,
2009). The hepatitis B virus (HBV) and hepatitis C virus (HCV) are
its most important risk factors; causal links with dietary aflatoxin
exposure and chronic alcohol consumption have also been
established (Yu et al, 2000; Gomaa et al, 2008). Recently, smoking
was classified as a group 1 carcinogen for HCC by the International
Agency for Research on Cancer (IARC), and a significant inverse
relationship with socioeconomic status (SES) has been reported
(IARC Working Group on the Evaluation of Carcinogenic Risks to
Humans, 2004; Joshi et al, 2008; Spadea et al, 2009). However,
investigations of the independent and combined effects of these
factors have been inconclusive, and lacking in HBV-endemic and
HCC-prevalent areas.
Korea is an intermediate endemic area of HBV infection (3.7%
HB surface antigen (HBsAg)-positive rate), according to the Korea
National Health and Nutrition Examination Survey conducted in
2007 (Ministry for Health, Welfare and Family Affairs, and Korea
Centers for Diseases Control and Prevention, 2008). Hepatocellular
carcinoma is also the predominant cancer with age-standardised
incidence rates of 43.7 in men and 11.7 in women per 100000 (Shin
et al, 2007), higher than in areas of North America, Africa, some
parts of Asia, Europe, and Oceania (Curado et al, 2007). The
independent and combined effects of HCC risk factors, including
SES, have not been investigated.
We carried out a hospital-based, case–control study to
(1) identify the independent risk for HCC associated with HBV
and HCV infections, alcohol intake, cigarette smoking, and low
SES and (2) measure the combined effects of these exposures after
adjustment for other potential confounding variables.
SUBJECTS AND METHODS
Liver cancer patients were recruited from October 2002 to
September 2006 based on information from the Order Commu-
nication System in the National Cancer Center Hospital (NCCH).
A total of 207 HCC cases were enrolled in the study following
medical chart examination to determine which cases met the
inclusion criteria, such as newly diagnosed with HCC; having no
history of cancer before visiting NCCH; without chronic diseases
such as hypertension, diabetes mellitus, and liver disease, which
may affect of HCC risk; age 30 years or older; complete serological
profiles available for HBV and HCV; data available on alcohol
intake, smoking, and family income; able to communicate with the
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yinterviewer; and who provided informed consent. The comparison
group was recruited from health examinees visiting the same hospital
for routine health check-ups, including cancer screenings, from May
2001 to May 2007 and identified as cancer free. Of 24889 health
examinees, 12731 met the eligibility criteria applied to cases. Finally,
828 controls were selected through random frequency matching to
provide four controls per case in the gender and age categories.
Individuals were interviewed by a trained interviewer using
a structured questionnaire. The baseline surveys collected
information on age (years 30–39, 40–49, 50–59, 60–69, 70 and
over), gender, marital status (married, single, including widowed
and divorced), average family income (oUS$2000, 2000–4000,
X4000 per month), alcohol intake, cigarette smoking, and BMI
(kgm
 2; o25, 25–30, X30).
The questionnaire on alcohol intake included drinking status
(never, former, current); weekly number of drinks of the five
most commonly consumed alcoholic beverages in Korea: soju
(Korean compound liquor), beer, whisky, makkolli (Korean
unstrained rice wine), and wine; age the subject started to drink
alcohol; and duration of the habit. Taking into account different
ethanol concentrations, alcohol consumption per volume for the
five beverages was quantified by multiplying the absolute alcohol
concentration by the volume of one drink for each type of
beverage. Lifetime alcohol intake was divided into three groups
(o24g per day, which included non-drinkers, 424g per day
but o48g per day, and 448g per day) (National Institute on
Alcohol Abuse and Alcoholism, 1992) for the analysis.
Cigarette smoking was classified as never, former, or current,
with former and current smokers grouped together for the analysis.
For former or current smokers, the average number of cigarettes
smoked per day and duration of smoking was obtained. The former
being classified as less than or more than 20 cigarettes per day.
Table 1 HCC cases and controls by selected characteristics with ORs and 95% CIs
Case, N¼207 (%) Control, N¼828 (%) P-value
a OR (95% CI)
b OR (95% CI)
c
Gender
Male 165 (79.7) 660 (79.7) — —
Female 42 (20.3) 168 (20.3) — —
Age group (years)
30–39 6 (2.9) 24 (2.9) — —
40–49 32 (15.4) 128 (15.4) — —
50–59 85 (41.1) 340 (41.1) — —
60–69 70 (33.8) 280 (33.8) — —
X70 14 (6.8) 56 (6.8) — —
Marital status
Coupled 186 (89.7) 784 (94.7) 0.0104 Reference Reference
Single (bereaved or divorced or not married) 21 (10.1) 44 (5.3) 2.01 (1.68–3.47) 0.52 (0.18–1.46)
Family income (US$ per month)
X4000 41 (19.8) 459 (55.4) o0.0001 Reference Reference
o4000 74 (35.8) 235 (28.4) 3.77 (2.48–5.73) 4.26 (2.15–8.46)
o2000 92 (44.4) 134 (16.2) 9.67 (6.19–15.09) 9.03 (4.21–19.40)
P-value for trend o0.0001
Lifetime alcohol intake (absolute alcohol concentration, g per day)
o24 124 (59.9) 632 (76.3) o0.0001 Reference Reference
o48 23 (11.1) 99 (12.0) 1.21 (0.74–1.99) 1.64 (0.66–4.06)
X48 60 (29.0) 97 (11.7) 3.29 (2.24–4.84) 2.79 (1.34–5.80)
P-value for trend 0.0052
Cigarette smoking
Never 74 (35.8) 403 (48.7) o0.0001 Reference Reference
Ever (current smoker or ex-smoker) 133 (64.3) 425 (51.3) 1.74 (1.26–2.40) 2.37 (1.17–4.79)
o20 cigarettes per day 46 (22.2) 198 (23.9) 1.29 (0.85–1.94) 0.94 (0.45–1.97)
X20 cigarettes per day 87 (42.0) 227 (27.4) 2.13 (1.49–3.03) 2.37 (1.17–4.79)
P-value for trend 0.0227
BMI (kgm
 2)
o25 155 (58.6) 473 (47.9) o0.0001 Reference Reference
25–30 48 (23.2) 309 (38.9) 0.473 (0.332–0.674) 0.49 (0.27–0.91)
X30 4 (1.9) 25 (3.1) 0.487 (0.165–1.436) 0.18 (0.04–0.87)
P-value for trend 0.0059
HbsAg
Negative 46 (22.2) 781 (94.3) o0.001 Reference Reference
Positive 161 (77.8) 47 (5.7) 79.06 (48.04–130.13) 149.33 (77.25–288.65)
Anti-HCV antibody
Negative 183 (88.4) 823 (99.4) o0.001 Reference Reference
Positive 24 (11.6) 5 (0.6) 23.54 (8.74–63.36) 185.05 (51.61–663.45)
Abbreviations: HbsAg¼serologic marker of hepatitis B virus surface antigen; anti-HCV antibody¼serologic marker of hepatitis C virus antibody; BMI¼body mass index;
OR¼odds ratio; 95% CI¼95% confidence interval.
aGender- and age-adjusted Cochran–Mantel–Haenszel w
2-test.
bMultiple logistic regression analysis adjusted for gender
and age.
cMultiple logistic regression analysis adjusted for gender, age, marital status, family income, lifetime alcohol intake, cigarette smoking, BMI, and positivity of HBsAg and
anti-HCV as appropriate.
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HBsAg and HCV antibody (anti-HCV) by enzyme-linked immuno-
sorbent assays (HBsAg (V2) and HCV (V3), AxSYM System;
Abott, Abbott Park, IL, USA).
Statistical methods
w
2-Tests were used to assess the significance of differences in the
distributions of categorical variables between subjects in the case
and control groups. Odds ratios (ORs) with corresponding 95%
confidence intervals (95% CIs) for the risk of HCC were estimated
by stratified analysis and unconditional logistic regression
modelling. The likelihood ratio test, which is the difference
between the maximised log-likelihood statistics, was used to assess
the significance of additional covariates in the model (Breslow and
Day, 1980). All the analyses were carried out using the SAS
statistical package (SAS Institute, Cary, NC, USA), and Po0.05
was considered statistically significant. The combined effects of
risk factors were computed by applying the synergic index (SI)
proposed by Rothman (1976).
The study was approved by the ethical committee of the
National Cancer Center. Informed consent for interviews and for
use of laboratory data was obtained from each subject.
RESULTS
Distribution of socio-demographic characteristics, alcohol con-
sumption, cigarette smoking, BMI, and hepatitis virus infection is
presented in Table 1. There were more single individuals among
the cases than the controls. Cases were in relatively lower income
levels and were more likely to be heavy drinkers and to be
smokers. Among cases, 77.8% were positive for HBsAg and 11.6%
were positive for anti-HCV, whereas among controls, 5.7% were
positive for HBsAg and 0.6% were positive for anti-HCV. Only one
of the cases (0.5%) and one of the controls (0.1%) tested positive
for both HBsAg and anti-HCV. HbsAg- and anti-HCV-positive
rates were 149.3 and 185.1 times higher in cases than controls
respectively. These differences were statistically significant after
adjustment for the other covariates listed in Table 1. Increased risk
of HCC was associated with low family income, heavy alcohol
consumption, and heavy smoking, whereas higher BMI was
associated with reduced risk of HCC. These differences in risk
for HCC between the case and control groups were statistically
significant (Table 1).
Odds ratios and CIs for the evaluation of interactions among
selected HCC risk factors by HBsAg and anti-HCV status were also
calculated. An inverse association was found with family income
level among subjects with HBsAg and/or anti-HCV (OR for
oUS$4000 vs X4000: 5.38, 95% CI: 2.14–13.53; OR for oUS$2000
vs X4000: 5.17, 95% CI: 1.89–14.16) and with neither HBsAg
nor anti-HCV (OR for oUS$4000 vs X4000: 14.93, 95% CI: 1.77–
125.84, OR for oUS$2000 vs X4000: 61.71, 95% CI: 7.43–513.81),
even if it was around 12 times higher among subjects with neither
HBsAg nor anti-HCV than among subjects with HBsAg and/or
anti-HCV. Higher lifetime alcohol intake was also associated with
increased risk of HCC among subjects with HBsAg and/or anti-
HCV (OR: 3.03, 95% CI: 1.13–8.18) and among subjects with
neither HBsAg nor anti-HCV (OR: 4.01, 95% CI: 1.22–13.22),
although significantly increased ORs were found only among heavy
drinkers (X48g per day) in both groups. Smoking more than
20 cigarettes per day increased the risk of HCC among subjects
with HBsAg and/or anti-HCV (OR: 4.11, 95% CI: 1.44–11.70), whereas
having a BMI 425kgm
 2 decreased HCC risk among subjects with
neither HBsAg nor anti-HCV (OR: 0.16, 95% CI: 0.03–0.73) only.
These linear trends for increasing risk of HCC were significant in
Table 2 OR and 95% CI for the association of HCC with selected risks by HBsAg and/or anti-HCV status
Subject with HBsAg and/or anti-HCV Subject without HBsAg and anti-HCV
Case,
N¼184 (%)
Control,
N¼51 (%) OR (95% CI)
a
Case,
N¼23 (%)
Control,
N¼777 (%) OR (95% CI)
a
Family income (US$ per month)
X4000 40 (21.7) 26 (51.0) Reference 1 (4.35) 433 (55.7) Reference
o4000 67 (36.4) 14 (27.5) 5.38 (2.14–13.53) 7 (30.4) 221 (28.4) 14.93 (1.77–125.84)
o2000 77 (41.85) 11 (21.6) 5.17 (1.89–14.16) 15 (65.2) 123 (15.8) 61.74 (7.43–513.81)
P-value for trend 0.0014 P-value for trend o0.0001
Lifetime alcohol intake (absolute alcohol concentration, g per day)
o24 113 (61.4) 39 (76.5) Reference 11 (47.8) 593 (76.3) Reference
24–48 18 (9.8) 4 (7.8) 1.27 (0.33–4.87) 5 (21.7) 95 (12.2) 1.73 (0.50–6.03)
X48 53 (28.8) 8 (15.7) 3.03 (1.13–8.18) 7 (30.4) 89 (11.5) 4.01 (1.22–13.22)
P-value for trend 0.0233 P-value for trend 0.0141
Cigarette smoking (pack per day)
Never 70 (38.4) 23 (54.0) Reference 4 (17.4) 380 (48.9) Reference
Ex- or current smoker smoked
o20 cigarettes per day
38 (20.7) 18 (35.3) 0.66 (0.27–1.61) 8 (34.8) 180 (23.2) 3.67 (0.94–14.28)
Ex- or current smoker smoked
X20 cigarettes per day
76 (41.3) 10 (19.6) 4.11 (1.44–11.70) 11 (47.8) 217 (27.9) 2.93 (0.79–10.95)
P-value for trend 0.0162 P-value for trend 0.0905
BMI (kgm
 2)
a
o25 134 (72.8) 31 (62.0) Reference 21 (91.3) 442 (58.4) Reference
25–30 46 (25.0) 16 (32.0) 0.64 (0.29–1.42) 2 (8.7) 293 (38.7) 0.16 (0.03–0.73)
X30 4 (2.17) 3 (6.0) 0.19 (0.29–1.03) 0 (0.0) 22 (2.9) —
P-value for trend 0.0794 P-value for trend 0.0039
Abbreviations: HBsAg¼serologic marker of hepatitis B virus surface antigen; anti-HCV antibody¼serologic marker of hepatitis C virus antibody; BMI¼body mass index;
OR¼odds ratio; 95% CI¼95% confidence interval.
aMultiple logistic regression analysis adjusted for gender, age, marital status, family income, lifetime alcohol intake, cigarette
smoking, and BMI as appropriate.
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models (Table 2).
Table 3 presents the independent and combined effects of HBV
and other selected risk factors. Definite independent risk of both
HBsAg positivity (OR: 158.66, 95% CI: 83.00–303.30) and anti-
HCV positivity (OR: 255.71, 95% CI: 64.71–999.99) were identified
when the effects of other potential risk factors were considered.
However, no combined effect of HBsAg and anti-HCV positivity
was found (SI: 0.04, 95% CI: 0.00–1.02). Independent and
combined effects of HBsAg and other selected risk factors were
also identified. Lifetime alcohol consumption (OR: 2.96, 95% CI:
1.29–6.79), cigarette smoking (OR: 3.53, 95% CI: 1.31–9.52), and
family income (OR: 17.07, 95% CI: 4.27–68.25) were independently
associated after controlling for the effects of HBsAg positivity and
after adjustment for other covariates, although the independent
risk of HBsAg positivity was much higher in each comparison. The
combined effect of low family income and HBsAg positivity was
more than additive and was statistically significant (SI: 3.12, 95%
CI: 1.51–6.47). The combined effect of lifetime alcohol intake and
cigarette smoking with HBsAg positivity was marginal (SI: 2.36;
95% CI: 0.99–5.65) and was not statistically significant (Table 3).
No independent or combined effects of potential risk factors
associated with anti-HCV positivity were found to be statistically
significant due to the small number of anti-HCV-positive subjects
in both the case and control groups (data not shown).
Table 4 presents the pairwise interaction of family income,
lifetime alcohol intake, and cigarette smoking on risk of HCC.
An independent risk of family income for lifetime alcohol intake
(OR: 4.55, 95% CI: 2.20–9.39) and cigarette smoking (OR: 2.56,
95% CI: 1.04–6.32) was found. Heavy drinkers (X24g per day)
with lower income (oUS$4000 per month) were at very high risk
for HCC relative to non-drinkers or moderate drinkers who
reported family income 4US$4000 per month. The combined
effect was more than the sum of the two individual effects (SI: 2.93,
95% CI: 1.24–6.89). Independent risk of cigarette smoking for
alcohol intake and of alcohol intake for cigarette smoking was
also found, although in combination they were not statistically
significant.
DISCUSSION
There is more than one risk factor for HCC, and risk estimation
is not simply additive; it can increase dramatically when two
risk factors are present concomitantly. These attributes make
simple risk estimation and establishment of strategic plans for
HCC prevention and clinical intervention difficult. Therefore,
some studies have addressed the independent and combined
effects of viral infection and other potential risk factors, including
alcohol consumption and smoking behaviour (Kuper et al, 2000;
Mori et al, 2000; Jee et al, 2004; Yuan et al, 2004; Ribes et al, 2008).
However, for HCC-prevalent areas, studies on the independent and
combined effect of these risk factors are lacking.
An important finding is the combined effect of HCC risk with
low family income, heavy alcohol intake, and HBV infection, in
addition to a significant inverse association with low family
income that have risk factors for HCC. Few studies have investi-
gated SES in addition to other exposures to measure the indepen-
dent and combined effects on risk of HCC (Joshi et al, 2008;
Spadea et al, 2009). A direct association between cancer and
SES could not be established and there is lack of studies of the
relative or attributable risk of SES adjusting for demographic
and behavioural factors (Yu et al, 2000; Ji and Hemminki, 2005;
Gwenn et al, 2007). Our findings suggest a definite independent
and combined effect of low SES on risk of HCC when using family
income as a direct indicator of SES in a multivariate model
Table 3 Interaction of HBsAg and anti-HCV positivity, alcohol intake, cigarette smoking, and family income on HCC risk
Factor 1 Factor 2 Case, N¼207 (%) Control, N¼828 (%) OR (95% CI)
a
HBsAg Anti-HCV
Negative Negative 23 (11.1) 777 (93.8) Reference
Negative Positive 23 (11.1) 4 (0.5) 255.71 (64.71–N)
Positive Negative 160 (77.3) 46 (5.6) 158.66 (83.00–303.30)
Positive Positive 1 (0.5) 1 (0.1) 15.90 (0.75–335.51)
SI and 95% CI: 0.04 (0.00–1.02)
b
HBsAg Lifetime alcohol intake
(Absolute alcohol concentration, g per day)
Negative o24 25 (12.1) 596 (72.0) Reference
Negative X24 21 (10.1) 185 (22.3) 2.96 (1.29–6.79)
Positive o24 99 (47.8) 36 (4.4) 153.99 (72.51–327.00)
Positive X24 62 (30.0) 11 (1.3) 367.11 (135.48–994.74)
SI and 95% CI: 2.36 (0.99–5.65)
b
HBsAg Cigarette smoking
Negative Never 13 (6.3) 382 (46.1) Reference
Negative Ever 33 (15.9) 399 (48.2) 3.53 (1.31–9.52)
Positive Never 61 (29.5) 21 (2.5) 363.79 (120.65–N)
Positive Ever 100 (48.3) 26 (3.1) 317.62 (109.22–923.60)
SI and 95% CI: 0.87 (0.39–1.92)
b
HBsAg Family income (US$ per month)
Negative X4000 4 (1.9) 436 (52.7) Reference
Negative o4000 42 (20.3) 345 (41.7) 17.07 (4.27–68.25)
Positive X4000 37 (17.9) 23 (2.8) 531.97 (121.16–N)
Positive o4000 124 (59.9) 24 (2.9) 4999.99 (397.07–N)
SI and 95% CI: 3.12 (1.51–6.47)
b
Abbreviations: HbsAg¼serologic marker of hepatitis B virus surface antigen; anti-HCV antibody¼serologic marker of hepatitis C virus antibody; OR¼odds ratio; 95% CI¼95%
confidence interval.
aMultiple logistic regression analysis adjusted for gender, age, marital status, family income, lifetime alcohol intake, cigarette smoking, BMI, and positivity of
HBsAg and anti-HCV as appropriate.
bSI: synergic index¼(OR11 1)/(OR01+OR10 2), in which OR11¼odds ratio of the joint effect of two risk factors; OR01 and OR10¼odds
ratio of each risk factor in the absence of the other.
SES, viral hepatitis, alcohol, and HCC
EH Yun et al
744
British Journal of Cancer (2010) 103(5), 741–746 & 2010 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yadjusted for other risk factors. In particular, the independent and
combined effect of low SES was larger among subjects with neither
HBsAg nor anti-HCV, which corresponds with IARC’s summary of
the differential presence, magnitude, and consistency of SES in
mortality and incidence (Faggiano et al, 1997).
Recently, a definitive carcinogenic effect of alcohol consumption
on HCC has been shown (Corrao et al, 2004; Tanaka et al, 2008),
and some studies have suggested a significant combined effect
(Kuper et al, 2000; Yuan et al, 2004; Marrero et al, 2005; IARC
Working Group on the Evaluation of Carcinogenic Risks to
Humans, 2007). However, the carcinogenic effects of alcohol are
often underestimated, and there is a lack of research in East Asia,
where alcohol consumption is increasing (Morgan et al, 2004;
Boffetta and Hashibe, 2006). Our study results suggest an
independent, rather than additive, combined risk for alcohol
intake and HBsAg (OR: 2.36; 95% CI: 0.99–5.65) in HBV-endemic
and HCC-prevalent areas, although the association was not
statistically significant. Furthermore, a significant combined effect
for heavy alcohol consumption and low family income was also
found.
A number of case–control and cohort studies have investigated
smoking in relation to HCC risk and its interaction with risk for
other diseases (Kuper et al, 2000; Mori et al, 2000; Jee et al, 2004;
Yuan et al, 2004; Marrero et al, 2005), and a causal relationship
between smoking and HCC has been established (IARC Working
Group on the Evaluation of Carcinogenic Risks to Humans, 2004).
However, studies are rare in HBV-endemic regions (Yu et al,
2000), and our study suggests a relatively modest association
between smoking and HCC, which could be caused by residual
confounding from alcohol intake; we found no combined effect for
cigarette smoking and other risk factors.
The present study suggests a significant, dose–response,
preventive effect of higher BMI, although only among subjects
with neither HBsAg nor anti-HCV, which is consistent with the
World Cancer Research Fund and American Institute for Cancer
Research (2007, p. 277) report. However, these results are not
consistent with a meta-analysis of large-scale cohort studies, some
of which have failed to show significant risk associated with
BMI or have not considered other risk factors (Key et al, 2004;
Larsson and Wolk, 2007; Ohki et al, 2008; Renehen et al, 2008;
Song et al, 2008). We were able to measure the relative
contribution of obesity itself without confounding from chronic
disease such as diabetes mellitus, hypertension, and liver cirrhosis,
and other risk factors to be considered (Yuan et al, 2004). To
clarify these inconsistencies, it is necessary to carry out further
comprehensive prospective studies on the association between
obesity and HCC.
To date, few studies have covered behavioural risk factors and
SES in HCC irrespective of viral infection. There is also little
evidence for interaction effect of these factors in viral infection-
status subgroups, but the results of our study suggest independent
risks associated with family income, lifetime alcohol intake,
cigarette smoking, and BMI in such subgroups. These findings
are relevant to prevention and intervention plans for HCC based
on HBV and HCV prevalence in specific areas.
A recent meta-analysis of 32 studies and 1 study from Korea
suggested independent and more than additive combined effects of
viral infection in HCC causation (Sato et al, 1994; Donato et al,
1998; Montalto et al, 2002; Kirk et al, 2004). Our study findings
also suggest that viral infection is a strong risk factor for HCC,
with a larger independent effect for anti-HCV positivity than for
HBsAg positivity. However, we observed no combined effect for
concomitant infection with both types of viruses, which may be
partly attributable to our small number of subjects co-infected
with HBV and HCV, with low anti-HCV antibody rates (estimated
around 1.3%) in Korea (Shin, 2006).
This study has several limitations. Certain chronic diseases, such
as diabetes mellitus and liver cirrhosis, that are suggested to
influence HCC development (Jee et al, 2004; Yuan et al, 2004;
Marrero et al, 2005; Boffetta and Hashibe, 2006; Park et al, 2006)
unlikely affected our findings, as we excluded subjects with these
diseases. Dietary and genetic susceptibility factors were not
covered. Our control group was recruited through routine health
check-ups, and as participation in such check-ups may reflect a
concern for health or the practice of healthy habits, this may have
biased the estimation of risk prevalence or HCC development.
However, we did adjust for major lifestyle factors, such as alcohol,
smoking, income, and BMI, in the analyses. Recall bias could also
Table 4 Pairwise interaction of family income, lifetime alcohol intake, and cigarette smoking on risk of HCC
Factor 1 Factor 2 Case, N¼183 (%) Control, N¼823 (%) OR (95% CI)
a
Family income (US$ per month) Lifetime alcohol intake
(absolute alcohol concentration, g per day)
X4000 o24 25 (12.1) 344 (41.6) Reference
X4000 X24 16 (7.7) 115 (13.9) 2.02 (0.73–5.58)
o4000 o24 99 (47.8) 288 (34.8) 4.55 (2.20–9.39)
o4000 X24 67 (32.4) 81 (9.8) 13.96 (5.74–33.97)
SI and 95% CI: 2.93 (1.24–6.89)
b
Family income (US$ per month) Cigarette smoking
X4000 Never 17 (8.2) 214 (25.9) Reference
X4000 Ever 24 (11.6) 245 (29.6) 0.70 (0.26–1.87)
o4000 Never 57 (27.5) 189 (22.8) 2.56 (1.04–6.32)
o4000 Ever 109 (52.7) 180 (21.7) 6.11 (2.47–15.12)
SI and 95% CI: 4.08 (0.81–20.56)
Lifetime alcohol intake (absolute
alcohol concentration, g per day)
Cigarette smoking
o24 Never 60 (29.0) 369 (44.6) Reference
o24 Ever 64 (30.9) 263 (31.8) 2.15 (1.07–4.32)
X24 Never 14 (6.8) 34 (4.11) 7.10 (2.17–23.23)
X24 Ever 69 (33.3) 162 (19.6) 4.20 (2.02–8.76)
SI and 95% CI: 0.44 (0.13–1.52)
b
Abbreviations: OR¼odds ratio; 95% CI¼95% confidence interval.
aMultiple logistic regression analysis adjusted for gender, age, marital status, family income, lifetime alcohol
intake, cigarette smoking, BMI, and positivity of HBsAg and anti-HCV as appropriate.
bSI: synergic index¼(OR11 1)/(OR01.+OR10 2), in which OR11¼odds ratio of the joint
effect of two risk factors; OR01 and OR10¼odds ratio of each risk factor in the absence of the other.
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comprehensive, structured questionnaires were used.
The findings of this study may further the understanding of
HCC aetiology, with or without the presence of viral hepatitis.
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